Srinivas Viswanathan MD, PhD
srviswanathan.bsky.social
Srinivas Viswanathan MD, PhD
@srviswanathan.bsky.social
Physician-scientist | GU oncologist @DanaFarber @Harvardmed
https://viswanathanlab.dana-farber.org
Cancer genomics, functional genetics, RNA
Prostate Cancer; translocation RCC. Opinions my own.
Reposted by Srinivas Viswanathan MD, PhD
The City of Boston is leading 40+ mayors, cities, and counties in an amicus brief against the Trump Administration's drastic and illegal cuts to federal research funding—cuts that will lead to immediate job losses nationwide.
February 20, 2025 at 10:17 PM
Excited to share our new study on translocation RCC (tRCC) in collaboration with @liron1bar-peled.bsky.social. We reveal how the TFE3 fusion drives a key oxidative phosphorylation (OXPHOS) metabolic program in this rare kidney cancer. trebuchet.public.springernature.app/get_content/... 1/
February 6, 2025 at 2:13 PM
Reposted by Srinivas Viswanathan MD, PhD
Our paper in @nature.com is finally published: a prospective trial of a personalized Neoantigen Vaccine in Kidney Cancer

www.nature.com/articles/s41...

This is teamwork with @danafarber.bsky.social @yalecancer.bsky.social @harvardmed.bsky.social + Wu lab

www.nature.com/articles/s41...
February 5, 2025 at 7:18 PM